Go to content
UR Home

Buparlisib modulates PD-L1 expression in head and neck squamous cell carcinoma cell lines

Fiedler, Mathias ; Schulz, Daniela ; Piendl, Gerhard ; Brockhoff, Gero ; Eichberger, Jonas ; Menevse, Ayse N. ; Beckhove, Philipp ; Hautmann, Matthias G. ; Reichert, Torsten E. ; Ettl, Tobias ; Bauer, Richard J.


High expression of the immune checkpoint receptor PD-L1 is associated with worse patient outcome in a variety of human cancers, including head and neck squamous cell carcinoma (HNSCC). Binding of PD-L1 with its partner PD-1 generates an inhibitory signal that dampens the immune system. Immunotherapy, that is blocking the PD-1/PD-L1 checkpoint, has proven to be an effective tool in cancer therapy. ...


Owner only: item control page
  1. Homepage UR

University Library

Publication Server


Publishing: oa@ur.de
0941 943 -4239 or -69394

Dissertations: dissertationen@ur.de
0941 943 -3904

Research data: datahub@ur.de
0941 943 -5707

Contact persons